Toshio Doi
Papers
1
Total Citations
53
H-Index
1
About
Toshio Doi is a leading researcher in diabetic nephropathy, with a focus on the molecular mechanisms driving kidney damage in diabetes. His work centers on the role of advanced glycation end products (AGEs) and their contribution to diabetic complications. In his highly cited 2004 study, Doi demonstrated that AGEs increase the expression of HSP47, a collagen-specific chaperone protein, in a mouse model of diabetic nephropathy. He further showed that OPB-9195, an inhibitor of AGE formation, can suppress this effect, highlighting a potential therapeutic target. This research, with 53 citations, has been instrumental in understanding how AGEs promote fibrosis and kidney dysfunction. Doi’s contributions have advanced the field by linking protein chaperones to diabetic pathology, offering new avenues for intervention. His work remains a cornerstone for researchers exploring the interplay between metabolic stress and renal disease.
Research Focus
Key Achievements
Top Papers
- 1